New vaccine ‘to cut malaria risk by half’ – Africa – Al Jazeera English.

A new vaccine against malaria will help reduce African children’s risk
of acquiring the disease by about half, according to the first results
of an ongoing phase III trial. The vaccine has been developed by the
British pharmaceutical giant GlaxoSmithKline’s lab in Belgium. Known
as RTS, the vaccine is the first of its kind to attempt to block a
parasite, rather than bacteria or viruses.